Show Notes
Get an easy-to-follow breakdown of systemic anticancer treatments (SACT)! This episode explains how SACT works against cancer with simple analogies. We dive into traditional cytotoxic chemotherapy drugs and the mechanisms that make them effective. Great for healthcare professionals and anyone interested in cancer treatments. Tune in next week for the world of targeted therapies!
Show Notes
Systemic Anticancer Treatments (SACT) target the hidden and traveling aspects of cancer that surgery or radiation might miss.
They disrupt essential processes in cancer cells or harness the immune system against them.
Cytotoxic Chemotherapy works by disrupting cell division and damaging DNA.
Types of cytotoxic drugs:
Alkylating Agents (e.g., cyclophosphamide) disrupt DNA replication.
Antimetabolites (e.g., 5-FU) mimic essential cell building blocks to cause errors.
Antimicrotubule Agents (e.g., taxanes, vinca alkaloids) target cell division machinery.
DNA Topoisomerase Inhibitors (e.g., irinotecan) cause irreparable DNA breaks.
Cytotoxic drugs can affect healthy cells, leading to side effects.
SACT is often used in combination with surgery, radiation, or other therapies.
Next Episode: Targeted therapies and immunotherapy.
Feedback Form: https://forms.gle/ebaoNCNe9Hg2fAMk6
CPD IIOP Example: https://docs.google.com/document/d/1__hbl-9aO7CT7vCEV-RXgb4zFRYAApi7LIpYIoQy3sg/edit?usp=sharing
More from Irish Haematology Oncology Podcast
Eoin Tabb reports from Day 3 of the ISOPP CAPhO 2025 Symposium in Victoria, Canada. This episode delves into crucial discussions on Equity, Diversity, and Inclusion (EDI) in pharmacy practice, the benefits and risks of Artificial Intelligence (AI) in oncology, updates on preventing Cancer-Associated Thrombosis (CAT), and the implementation of pre-therapeutic Pharmacogenomics (PGx), including combining DPYD testing with Therapeutic Drug Monitoring (TDM) for 5-FU. Plus, hear exciting news from the ISOPP AGM about next year's unique 24-hour virtual conference format and a special collaboration with the Irish Pharmacy Haematology Oncology Society (IPHOS)! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy #EDI #AI #PGx #TDM #CAT CAT Survey: https://redcap.alfredhealth.org.au/redcap/surveys/index.php?s=dFo7DpNgVBauTYeW&__startover=1
Join Eoin Tabb for the second daily dispatch from the ISOPP CAPhO 2025 Symposium in Victoria, Canada. Day 2 covered a wide spectrum of crucial topics for haematology/oncology pharmacy practice. Highlights include practical management strategies for PARP inhibitors, the importance of cultural humility and discussing traditional medicines, ISOPP's new global service level framework, pharmacy's role in disaster preparedness and environmental sustainability, efficiencies in myeloma treatment administration (pre-meds, infusion times, schedules), managing CMV infections, considerations for treating older/unfit patients using geriatric assessment, and critical updates on hazardous drug lists and safety. Tune in for key insights and takeaways relevant to Irish practice! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy PARPi Clinical Resource: https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/endorsements/en_parp_inhibitor_clinical_r.pdf
Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering: